bhp
Est. dry powder
—
Not reported
AUM
—
Not reported
Latest fund
—
bhp No.2, size not reported
Est. cheque size
$256.2K–
From fund sizes
Deals, last 12 months
—
Not reported
About bhp
Biotech Healthcare Partners (bhp) is a Tokyo-based venture capital firm that focuses on the biotechnology and healthcare sectors. The firm targets seed and start-up early stage companies and provides both hands-on and financial support for growth and aims to exit its investments via IPOs. On October 20, 2021, the firm registered for official business closure.
- Type
- Venture Capital Firm
- Headquarters
- Tokyo, Tokyo, Japan
- Stages
- SeedSeries ASeries BEarly Stage
- Est. cheque size
- $256.2K–$1.3M
- Sectors
- Healthcare
- Regions
- Asia
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series A1
- Series B1
Across 2 deals
Portfolio sectors
- Pharmaceuticals1
- Software1
Across 2 companies
Portfolio countries
- UK1
- US1
Across 2 companies
Recent investments
Newest 2 of 2
- Series A$19.8M
Circulor Ltd
Jun 2021 · Series A
- Series B$29M
MediciNova, Inc.
Jun 2004 · Series B
Offices
1 location
- Tokyo, Tokyo, JapanHQ
Questions about bhp
How much does bhp invest per deal?
Based on the size of its funds, bhp writes estimated cheques of $256.2K–$1.3M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does bhp invest in?
bhp has invested at Seed, Series A, Series B and Early Stage. Its most frequent rounds on record are Series A and Series B.
What has bhp invested in recently?
Recent investments include Circulor Ltd and MediciNova, Inc..